Head of Investor Relations
SCHOTT Pharma AG & Co. KGaA
Equibles does not estimate personal net worth.
Tobias Erfurt is recorded as Head of Investor Relations at SCHOTT Pharma AG & Co. KGaA. Tobias Erfurt has spoken on 3 earnings calls across 1 company, most recently for SCHOTT Pharma AG & Co. KGaA on August 12, 2026. SCHOTT Pharma AG & Co. KGaA is classified in the Medical Instruments & Supplies industry within the Healthcare sector.
“With me are our CEO, Christian Mears, and our CFO, Reinhard Meyer. Christian will begin with a business update, followed by Reinhard, who will walk you through our financial performance in more detail.”
“Good morning, everyone, and welcome to SHOT Pharma's earnings call for the first half of financial year 2026. My name is Tobias Erfurt, Head of Investor Relations, and I will guide you through today's session.”
“Good morning, everyone, and welcome to SHOTS Pharma's earnings call for the first quarter financial year 2026. My name is Tobias Erfurt, Head of Investor Relations, and I will be guiding you through today's call and webcast.”
SCHOTT Pharma AG & Co. KGaA
Head of Investor Relations
Transcript header (unverified)
SCHOTT Pharma AG & Co. KGaA
Medical Instruments & Supplies · Healthcare
Head of Investor Relations
Quarterly statement (9M 2026)
SCHOTT Pharma AG & Co. KGaA
Half-year report (H1 2026)
SCHOTT Pharma AG & Co. KGaA
Quarterly statement (Q1 2026)
SCHOTT Pharma AG & Co. KGaA
